Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as ...

Hims & Hers Health, Inc. (NYSE:HIMS) announced the acquisition of a California-based peptide facility to enhance its domestic ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Rosa Parks was an avid yoga practitioner. The way Parks took a stand for civil rights reflects many of the principles behind ...

Violin teacher Constance Meyer’s chronic hacking cough was driving other people crazy. The mother of a new student figured ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food ...

Now Medicaid work requirements may be coming back soon as part of a proposed $2.3 trillion spending cut to the program. Trump ...

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

The FDA just slammed the door on its booming weight-loss drug business--but Hims & Hers has a bold new strategy.